Dr. Amy Abernethy, principal deputy commissioner at the U.S. FDA, discusses the need for regulatory "agility" during the COVID-19 pandemic. EMEA Government & Policy By HIMSS TV | September 15, 2020 | 6:00 PM Topic: Government & Policy, Population Health, Women In Health IT